General MedicationsORALStandard

ATOMOXETINE HYDROCHLORIDE

Standard Dose

EQ 60MG BASE

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview ATOMOXETINE HYDROCHLORIDE is listed in Drugs@FDA under application 202682 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ATOMOXETINE HYDROCHLORIDE Form and strength CAPSULE;ORAL - EQ 60MG BASE Sponsor HETERO LABS LTD V Submission history Latest submission status date: 2023-05-08 00:00:00.

Structured Monograph

Clinical summary

Approval overview ATOMOXETINE HYDROCHLORIDE is listed in Drugs@FDA under application 202682 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ATOMOXETINE HYDROCHLORIDE Form and strength CAPSULE;ORAL - EQ 60MG BASE Sponsor HETERO LABS LTD V Submission history Latest submission status date: 2023-05-08 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.